Physician profile
David Q Sun
NPI 1538506464
$10,486.58
in general payments reported to CMS, 2019-2025
17 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,136 · 2020: $131 · 2021: $1,344 · 2022: $255 · 2023: $555 · 2024: $1,176 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,620.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,312.53 | 2019-2025 | Mako, Trident, Triathlon |
| Zimmer Biomet Holdings, INC. | $2,212.51 | 2019-2025 | Persona, Rosa, Mymobility Platform |
| Medacta USA, INC. | $1,964.58 | 2019-2020 | |
| Medical Device Business Services, INC. | $741.80 | 2019 | |
| Smith+Nephew, INC. | $542.61 | 2019 | |
| Depuy Synthes Sales INC. | $330.77 | 2019-2023 | Monovisc, Orthovisc |
| Carbofix Orthopedics INC | $103.00 | 2022 | |
| Medinc of Texas | $77.23 | 2024-2025 | |
| Ermi LLC | $32.72 | 2020-2021 | |
| Heron Therapeutics, INC. | $31.04 | 2024 | Zynrelef |
| Integra Lifesciences Corporation | $29.28 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.52 | 2023 | Zilretta, Iovera |
| Vericel Corporation | $22.63 | 2022 | |
| Kci USA, INC. | $21.47 | 2023 | Prevena |
| Ferring Pharmaceuticals INC. | $13.97 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.53 | 2021 | |
| Baudax Bio INC. | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.